Chris Comeaux and Robin Heffernan explore the evolving intersection of private equity, artificial intelligence, and end-of-life care—raising critical questions about accountability, quality, and the future of hospice under Medicare Advantage.
Empassion CEO, Robin Heffernan, explains supportive care, distinguishing palliative care (any stage) from hospice (typically the last six months), and describes Empassion’s model: contracting with payers so care is free to patients, curating a nationwide network of in-home providers, and using technology to coordinate care across teams in 46 states.
Chris Comeaux and Robin Heffernan unpack the complex realities shaping the future of hospice under Medicare Advantage.
Hear directly from our clients about their experiences with Empassion’s care and support.